JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Sheep Tyrosine Hydroxylase

Sheep Tyrosine Hydroxylase

Affinity purified sheep polyclonal antibody. The antibody has been tested in Western blots of SDS-solubilized human and mouse striatal samples and in IHC applications with monkey (Macaque) brain sections.

Skip to the end of the images gallery

Sheep Tyrosine Hydroxylase

Skip to the beginning of the images gallery

Product Datasheet

Specifications

Physical State: Liquid; Buffer contents: 10 mM HEPES (pH 7.5), 150 mM NaCl, 100 μg per mL BSA and 50% glycerol

Storage: At or -20°C

Applications: Western Blot,IHC,IF

Learn more

Size:

Product Code: Select size

Quantity:

Custom/Bulk request

Bulk Requirements for Human Serum

More n/a

From
$408.00

Lead time on this item is currently: 2-4 Weeks

Need help? Ask a Specialist Contact Us OR +1 (800) 643-3426

Product Overview

Product Overview
Clonality:	Polyclonal
Application:	Western Blot,IHC,IF
Species Reactivity:	Mammalian,Non-Mammalian
Storage Conditions:	-20°C Short term,-80°C Long term
Shipping Conditions:	Dry ice
Species:	Sheep
Application Notes:	Recommended starting dilution: WB, IF, IHC 1:1000
Guarantee:	Product quality is guaranteed to meet Pel-Freez Biologicals' specifications for 1 year from the date of receipt by the customer as long as the product is stored in accordance with the indicated storage conditions.
Packaging:	1.5 mL microtube

Product Applications

Western blot
ELISA
Immunofluorescence
Immunohistochemistry

Documents & Datasheets

Product Datasheet

Datasheet for P60101 Sheep Tyrosine Hydroxylase Antibody Rev 02

Safety Datasheet

SDS for P60101 Sheep Tyrosine Hydroxylase Antibody

Product References

Fyn knockdown prevents levodopa-induced dyskinesia in a mouse model of Parkinson’s disease
Bordone, M. P. et al. Fyn knockdown prevents levodopa-induced dyskinesia in a mouse model of Parkinson’s disease. eneuro ENEURO.0559-20.2021 (2021).

An Optimized Protocol for the Generation of Midbrain Dopamine Neurons under Defined Conditions
Gantner, C. W., Cota-Coronado, A., Thompson, L. H. & Parish, C. L. An Optimized Protocol for the Generation of Midbrain Dopamine Neurons under Defined Conditions. STAR Protoc. 1, 100065 (2020).

β‑Lapachone ameliorates L‑DOPA‑induced dyskinesia in a 6‑OHDA‑induced mouse model of Parkinson's disease
Ryu, Y. K. et al. β-Lapachone ameliorates L-DOPA-induced dyskinesia in a 6-OHDA-induced mouse model of Parkinson’s disease. Mol. Med. Rep. 23, (2021).

Splenic artery loops: Potential splenic plexus stimulation sites for neuroimmunomodulatory‐based anti‐inflammatory therapy?
Cleypool, C. G. J., Lotgerink Bruinenberg, D., Roeling, T., Irwin, E. & Bleys, R. L. A. W. Splenic artery loops: Potential splenic plexus stimulation sites for neuroimmunomodulatory-based anti-inflammatory therapy? Clin. Anat. 34, 371–380 (2021).

Valproic Acid Significantly Improves CRISPR/Cas9-Mediated Gene Editing
Park, H., Shin, J., Choi, H., Cho, B. & Kim, J. Valproic Acid Significantly Improves CRISPR/Cas9-Mediated Gene Editing. Cells 9, (2020).

Neuroprotection and immunomodulation of progesterone in the gut of a mouse model of Parkinson's disease
Jarras, H. et al. Neuroprotection and immunomodulation of progesterone in the gut of a mouse model of Parkinson’s disease. J. Neuroendocrinol. 32, (2020).